121 related articles for article (PubMed ID: 25877634)
21. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
Filippi M; Preziosa P; Pagani E; Copetti M; Mesaros S; Colombo B; Horsfield MA; Falini A; Comi G; Lassmann H; Rocca MA
Mult Scler; 2013 Apr; 19(4):418-26. PubMed ID: 22907944
[TBL] [Abstract][Full Text] [Related]
22. Fractal dimension and white matter changes in multiple sclerosis.
Esteban FJ; Sepulcre J; de Mendizábal NV; Goñi J; Navas J; de Miras JR; Bejarano B; Masdeu JC; Villoslada P
Neuroimage; 2007 Jul; 36(3):543-9. PubMed ID: 17499522
[TBL] [Abstract][Full Text] [Related]
23. Improved contrast in multispectral phase images derived from magnetic resonance exams of multiple sclerosis patients.
Mitchell JR; Rutt BK
Med Phys; 2002 May; 29(5):727-35. PubMed ID: 12033569
[TBL] [Abstract][Full Text] [Related]
24. In vivo quantitative whole-brain T1 rho MRI of multiple sclerosis.
Gonyea JV; Watts R; Applebee A; Andrews T; Hipko S; Nickerson JP; Thornton L; Filippi CG
J Magn Reson Imaging; 2015 Dec; 42(6):1623-30. PubMed ID: 26032694
[TBL] [Abstract][Full Text] [Related]
25. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.
Santos AC; Narayanan S; de Stefano N; Tartaglia MC; Francis SJ; Arnaoutelis R; Caramanos Z; Antel JP; Pike GB; Arnold DL
J Neurol; 2002 Jun; 249(6):662-8. PubMed ID: 12111296
[TBL] [Abstract][Full Text] [Related]
26. Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.
Schocke MF; Berger T; Felber SR; Wolf C; Deisenhammer F; Kremser C; Seppi K; Aichner FT
Neuroimage; 2003 Oct; 20(2):1253-63. PubMed ID: 14568494
[TBL] [Abstract][Full Text] [Related]
27. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
28. Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
Sweeney EM; Shinohara RT; Dewey BE; Schindler MK; Muschelli J; Reich DS; Crainiceanu CM; Eloyan A
Neuroimage Clin; 2016; 10():1-17. PubMed ID: 26693397
[TBL] [Abstract][Full Text] [Related]
29. Subtle blood-brain barrier leakage rate and spatial extent: Considerations for dynamic contrast-enhanced MRI.
van de Haar HJ; Jansen JFA; Jeukens CRLPN; Burgmans S; van Buchem MA; Muller M; Hofman PAM; Verhey FRJ; van Osch MJP; Backes WH
Med Phys; 2017 Aug; 44(8):4112-4125. PubMed ID: 28493613
[TBL] [Abstract][Full Text] [Related]
30. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.
Neema M; Stankiewicz J; Arora A; Dandamudi VS; Batt CE; Guss ZD; Al-Sabbagh A; Bakshi R
J Neuroimaging; 2007 Apr; 17 Suppl 1():16S-21S. PubMed ID: 17425729
[TBL] [Abstract][Full Text] [Related]
31. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.
Rovaris M; Gallo A; Valsasina P; Benedetti B; Caputo D; Ghezzi A; Montanari E; Sormani MP; Bertolotto A; Mancardi G; Bergamaschi R; Martinelli V; Comi G; Filippi M
Neuroimage; 2005 Feb; 24(4):1139-46. PubMed ID: 15670691
[TBL] [Abstract][Full Text] [Related]
32. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
Bendfeldt K; Kuster P; Traud S; Egger H; Winklhofer S; Mueller-Lenke N; Naegelin Y; Gass A; Kappos L; Matthews PM; Nichols TE; Radue EW; Borgwardt SJ
Neuroimage; 2009 Mar; 45(1):60-7. PubMed ID: 19013533
[TBL] [Abstract][Full Text] [Related]
33. Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis.
van Walderveen MA; van Schijndel RA; Pouwels PJ; Polman CH; Barkhof F
J Magn Reson Imaging; 2003 Dec; 18(6):656-64. PubMed ID: 14635150
[TBL] [Abstract][Full Text] [Related]
34. Use of perfusion- and diffusion-weighted imaging in differential diagnosis of acute and chronic ischemic stroke and multiple sclerosis.
Zivadinov R; Bergsland N; Stosic M; Sharma J; Nussenbaum F; Durfee J; Hani N; Abdelrahman N; Jaisani Z; Minagar A; Hoque R; Munschauer FE; Dwyer MG
Neurol Res; 2008 Oct; 30(8):816-26. PubMed ID: 18826808
[TBL] [Abstract][Full Text] [Related]
35. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration.
Vrenken H; Pouwels PJ; Geurts JJ; Knol DL; Polman CH; Barkhof F; Castelijns JA
J Magn Reson Imaging; 2006 May; 23(5):628-36. PubMed ID: 16565955
[TBL] [Abstract][Full Text] [Related]
36. Can MS lesion stages be distinguished with MRI? A postmortem MRI and histopathology study.
Jonkman LE; Soriano AL; Amor S; Barkhof F; van der Valk P; Vrenken H; Geurts JJ
J Neurol; 2015; 262(4):1074-80. PubMed ID: 25761376
[TBL] [Abstract][Full Text] [Related]
37. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T.
Adhya S; Johnson G; Herbert J; Jaggi H; Babb JS; Grossman RI; Inglese M
Neuroimage; 2006 Dec; 33(4):1029-35. PubMed ID: 16996280
[TBL] [Abstract][Full Text] [Related]
38. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
[TBL] [Abstract][Full Text] [Related]
39. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis.
Laule C; Vavasour IM; Whittall KP; Oger J; Paty DW; Li DK; MacKay AL; Arnold DL
J Neurol; 2003 Aug; 250(8):924-31. PubMed ID: 12928910
[TBL] [Abstract][Full Text] [Related]
40. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
Barkhof F; van Walderveen M
Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
